Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy

OBJECTIVE: To evaluate the clinical efficacy and safety of leflunomide (LEF) combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy (PMN) and changes in anti-PLA2R antibody titers after treatment. METHODS: Sixty patients with nephrotic syndrome, biopsy-proven M...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yaling, Wu, Xueping, Liu, Lei, Zhang, Haifeng, Yang, Lijuan, Chen, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006764/
https://www.ncbi.nlm.nih.gov/pubmed/31957527
http://dx.doi.org/10.1080/0886022X.2020.1713806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006764/
https://www.ncbi.nlm.nih.gov/pubmed/31957527
http://dx.doi.org/10.1080/0886022X.2020.1713806

Ejemplares similares